Saba Capitalome & Opportunities Fund (Saba Capitalome & Opportunities Fund) Beneish M-Score : 0.00 (As of Jun. 08, 2024)

View and export this data going back to . Start your Free Trial

What is Saba Capitalome & Opportunities Fund Beneish M-Score?

Note: Financial institutions were excluded from the sample in Beneish paper when calculating Beneish M-Score. Thus, the prediction might not fit banks and insurance companies.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Saba Capitalome & Opportunities Fund's Beneish M-Score or its related term are showing as below:

During the past 6 years, the highest Beneish M-Score of Saba Capitalome & Opportunities Fund was -1.40. The lowest was -1.40. And the median was -1.40.

Saba Capitalome & Opportunities Fund Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Saba Capitalome & Opportunities Fund for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Oct23) TTM:

Last Year (Oct22) TTM:

Total Receivables was $325.71 Mil.
Revenue was $34.25 Mil.
Gross Profit was $34.25 Mil.
Total Current Assets was $0.00 Mil.
Total Assets was $649.97 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $1.41 Mil.
Total Current Liabilities was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $59.47 Mil.
Net Income was $30.60 Mil.
Gross Profit was $0.00 Mil.
Cash Flow from Operations was $165.87 Mil.

Total Receivables was $16.21 Mil.
Revenue was $-6.12 Mil.
Gross Profit was $-6.12 Mil.
Total Current Assets was $0.00 Mil.
Total Assets was $548.46 Mil.
Property, Plant and Equipment(Net PPE) was $0.00 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.00 Mil.
Selling, General, & Admin. Expense(SGA) was $2.42 Mil.
Total Current Liabilities was $0.00 Mil.
Long-Term Debt & Capital Lease Obligation was $175.50 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(325.705 / 34.248)	/	(16.213 / -6.115)
	=	9.51019	/
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(-6.115 / -6.115)	/	(34.248 / 34.248)
	=		/	1
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (0 + 0) / 649.972)	/	(1 - (0 + 0) / 548.46)
	=	1	/	1
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	34.248	/	-6.115
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0 / (0 + 0))	/	(0 / (0 + 0))
	=		/
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(1.414 / 34.248)	/	(2.419 / -6.115)
	=	0.041287	/
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((59.472 + 0) / 649.972)	/	((175.5 + 0) / 548.46)
	=	0.091499	/	0.319987
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(30.596 - 0	-	165.87)	/	649.972
	=	-0.208123

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Saba Capitalome & Opportunities Fund Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Saba Capitalome & Opportunities Fund's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Saba Capitalome & Opportunities Fund (Saba Capitalome & Opportunities Fund) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Saba Capital Income & Opportunities Fund (NYSE:BRW) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

405 Lexington Avenue, 58th Floor, New York, NY, USA, 10174

Website

https://www.sabacef.com

Saba Capital Income & Opportunities Fund t is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

Executives

Saba Capital Management, L.p.	10 percent owner	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Troy M Statczar	officer: Principle Financial Officer	3 CANAL PLAZA, PORTLAND ME 04101
Nitin Sapru	officer: Vice President	405 LEXINGTON AVE, 58TH FLOOR, NEW YORK NY 10174
Michael D'angelo	officer: Secretary	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Patrick J Keniston	officer: Chief Compliance Officer	FORESIDE COMPLIANCE SERVICES, LLC, THREE CANAL PLAZA, SUITE 100, PORTLAND ME 04101
Pierre Weinstein	officer: Chief Executive Officer	C/O SABA CAPITAL MANAGEMENT L.P., 405 LEXINGTON AVENUE, 5TH FLOOR, NEW YORK NY 10174
Christopher P Sullivan	other: Former Trustee	27 LEE TERRACE, SHORT HILLS NJ 07078
Thomas Bumbolow	director	C/O VOYA PRIME RATE TRUST, 7337 EAST DOUBLETREE RANCH RD., STE 100, SCOTTSDALE AZ 85258
Neal Neilinger	director	126 CLAPBOARD RIDGE ROAD, GREENWICH CT 06830
Charles I Clarvit	director	TWO INTERNATIONAL PLACE, BOSTON MA 02110
Kieran Goodwin	director	925 PARK AVENUE 11B, NEW YORK NY 10028
Ketu Desai	director	999 RIVERVIEW DR, SUITE 201, TOTOWA NJ 07512
Karen Caldwell	director	10125 SOUTH BELL AVENUE, CHICAGO IL 60643
Aditya Bindal	director	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174
Andrew Kellerman	director	405 LEXINGTON AVENUE, 58TH FLOOR, NEW YORK NY 10174